SLC6A1 and Alzheimer disease: In particular, gene expression analyses for both PSD-95 and GPHN transcripts and vGluT1 and GAT1 expressing cells in the ADTBI cohort of subjects, with late-onset AD and level of pathology similar to the ones used in FTD studies, also demonstrated a shift in E/I imbalance.